¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"background diabetic retinopathy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® diabetic neuropathy ÇÑ±Û ´ç´¢º´½Å°æº´Áõ
¼³¸í   
  ¿À·¡µÈ ´ç´¢ÀÇ ÇÕº´ÁõÀ¸·Î ¹ß»ýÇÑ´Ù. ´ë°³ ´ç´¢º´¿¡ ÀÌȯµÈ °æ¿ì ´ç´¢º´ ÀÚü¿¡ ÀÇÇÑ º´º¸´Ù ¿À·£ ±â°£ÈÄÀÇ ÇÕº´Áõ¿¡ ÀÇÇØ ¸ñ¼ûÀ» ÀҴ °æ¿ì°¡ ¸¹´Ù. Ãʱ⿡ ´ç´¢º´¿¡¼­ Ç÷Á߯÷µµ´ç³óµµ¸¦ Àß Á¶ÀýÇϴ °æ¿ì ÀÌ·± ÇÕº´ÁõÀÌ ¹ß»ýÇϴ °æ¿ì°¡ ³·À¸³ª, ±×·¸Áö ¸øÇÑ °æ¿ì ÇÕº´Áõ ¹ß»ýÀÌ ¸¹´Ù. ´ë°³ Çѹø ¹ß»ýÇÑ °æ¿ì, Ä¡·á´Â ¾î·Æ°í ±× ÁøÇà ¶ÇÇÑ ´ÊÃâ ¼ö ¾ø´Ù°í ÇÑ´Ù. Áõ»óÀº °¨°¢ÀÇ ÀúÇϸ¦ °¡Á®¿Í, ¾ÆÇÄÀ» Àß ´À³¢Áö ¸øÇϹǷΠÁÖÀ§ ¹°°ÇÀ̳ª »ç¶÷°ú Àß ºÎµúÈ÷°í, ºÎµúÈù ÈÄ¿¡µµ »ç½ÇÀ» ÀÎÁöÇÏÁö ¸øÇØ °è¼ÓÀûÀΠ¿Ü»óÀ» ¹Þ°Ô µÇ¹Ç·Î ºÎµúÈ÷±â ½¬¿î °üÀýÀ̳ª, ¹ß°¡¶ô, ¹ß¸ñºÎºÐ µî¿¡ ¼Õ»óÀ» °¡Á®¿Â´Ù.
¿µ¹® diabetic nephropathy ÇÑ±Û ´ç´¢º´ÄáÆÏº´Áõ
¼³¸í   
  ¿À·¡µÈ ´ç´¢ÀÇ ÇÕº´ÁõÀ¸·Î ¹ß»ýÇÑ´Ù. ´ë°³ ´ç´¢º´¿¡ ÀÌȯµÈ °æ¿ì ´ç´¢º´ ÀÚü¿¡ ÀÇÇÑ Áúº´º¸´Ù ¿À·£ ±â°£ÈÄÀÇ ÇÕº´Áõ¿¡ ÀÇÇØ ¸ñ¼ûÀ» ÀҴ °æ¿ì°¡ ¸¹´Ù. Ãʱ⿡ ´ç´¢º´¿¡¼­ Ç÷Áß Æ÷µµ´ç³óµµ¸¦ Àß Á¶ÀýÇÑ °æ¿ì ÀÌ·± ÇÕº´ÁõÀÌ ¹ß»ýÇϴ °æ¿ì°¡ ³·À¸³ª, ±×·¸Áö ¸øÇÑ °æ¿ì ½ÅÀåÀÇ ÇÕº´ÁõÀÌ ¹ß»ýÇÒ ¼ö ÀÖ´Ù. Çѹø ¹ß»ýÇÑ °æ¿ì, Ä¡·á´Â ºÒ°¡´ÉÇϸç, ±× ÁøÇà ¶ÇÇÑ ´ÊÃâ ¼ö ¾ø´Ù. Ä¡·á¹ýÀº ¿ÀÁ÷ Çϳª ÄáÆÏÀ̽ļú¿¡ ÀÇÇØ¼­¸¸ °¡´ÉÇϸç À̽ļúÀ» ½ÃÇàÇÑ ÀÌÈÄ¿¡µµ Ç÷´ç·®ÀÇ Á¶ÀýÀº ÇʼöÀûÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diabetic retinopathy
    ´ç´¢¸Á¸·º´(Áõ)
  • proliferative diabetic retinopathy
    Áõ½Ä´ç´¢¸Á¸·º´(Áõ)
  • background fluorescence
    ¹è°æÇü±¤
  • background gradient
    ¹è°æ±â¿ï±â
  • background inhomogeneity
    ¹è°æºÒ±ÕÁú¼º
  • background level
    ¹è°æ¼öÁØ
  • background noise
    ¹è°æÀâÀ½
  • background radiation
    1. ¹è°æ¹æ»ç 2. ¹è°æº¹»ç
  • angiospastic retinopathy
    Ç÷°ü¿¬Ãà¸Á¸·º´(Áõ)
  • bone marrow transplantation retinopathy
    °ñ¼öÀ̽ĸÁ¸·º´(Áõ)
  • circinate retinopathy
    °í¸®¸Á¸·º´(Áõ)
  • central disciform retinopathy
    Á߽ɿø¹ÝÇü¸Á¸·º´(Áõ)
  • central serous retinopathy
    Áß½ÉÀå¾×¸Á¸·º´(Áõ)
  • drug-induced retinopathy
    ¾à¹°À¯¹ß¸Á¸·º´(Áõ)
  • diabetic
    1. ´ç´¢º´- 2. ´ç´¢º´È¯ÀÚ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diabetic retinopathy
    ´ç´¢¸Á¸·º´Áõ
  • proliferative diabetic retinopathy
    Áõ½Ä´ç´¢¸Á¸·º´Áõ
  • background fluorescence
    ¹è°æÇü±¤
  • background noise
    ¹è°æÀâÀ½
  • diabetic nephropathy
    ´ç´¢º´ÄáÆÏº´Áõ
  • diabetic neuropathy
    ´ç´¢º´½Å°æº´Áõ
  • retinopathy
    ¸Á¸·º´Áõ
  • hypertensive retinopathy
    °íÇ÷¾Ð¸Á¸·º´Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diabetic retinopathy
    ´ç´¢¸Á¸·º´Áõ
  • proliferative diabetic retinopathy
    Áõ½Ä´ç´¢¸Á¸·º´Áõ
  • background fluorescence
    ¹è°æÇü±¤
  • background gradient
    ¹è°æ±â¿ï±â
  • background inhomogeneity
    ¹è°æºÒ±ÕÀÏ
  • background level
    ¹è°æ¼öÁØ
  • background noise
    ¹è°æÀâÀ½
  • background radiation
    ¹èÈĹæ»ç¼±
  • diabetic acidosis
    ´ç´¢º´»êÁõ
  • diabetic angiopathy
    ´ç´¢º´Ç÷°üº´Áõ
  • diabetic cataract
    ´ç´¢¹é³»Àå
  • diabetic collapse
    ´ç´¢º´ÇãÅ»
  • diabetic coma
    ´ç´¢È¥¼ö
  • diabetic
    ´ç´¢º´-
  • diabetic diet
    ´ç´¢º´½ÄÀÌ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • preproliferative diabetic retinopathy
    Áõ½ÄÀü´ç´¢¸Á¸·º´Áõ
  • proliferative diabetic retinopathy
    Áõ½Ä´ç´¢¸Á¸·º´Áõ(ñòãÖÓØèñØÑدܻñø).
  • proliferative diabetic retinopathy
    Áõ½Ä¼º ´ç´¢¼º ¸Á¸·º´Áõ(ñòãÖàõ ÓØèñàõ ØÑدܻñø)
  • glomerulosclerosis,diabetic
    ´ç´¢º´¼º
  • hypothalamic diabetic insipidus
    ½Ã»óÇϺμº ¿äºØÁõ
  • Purtschers traumatic retinopathy
    Ǫ¸£Ã³¿Ü»ó¸Á¸·º´Áõ
  • albuminuric retinopathy
    ´Ü¹é´¢¸Á¸·º´Áõ(¡­ØÑدæú).
  • anemic retinopathy
    ºóÇ÷¸Á¸·Áõ
  • angiospastic retinopathy
    Ç÷°ü¿¬Ãà¸Á¸·º´Áõ(¡­ØÑدñø).
  • hemorrhagic retinopathy
    ÃâÇ÷¸Á¸·º´Áõ
  • hypertensive retinopathy
    °íÇ÷¾Ð¸Á¸·º´Áõ
  • hypotensive retinopathy
    ÀúÇ÷¾Ð¸Á¸·º´Áõ
  • proliferative retinopathy
    Áõ½Ä¸Á¸·º´Áõ
  • quinine retinopathy
    Ű´Ï³×¸Á¸·º´Áõ
  • radiation retinopathy
    ¹æ»ç¼±¸Á¸·º´Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • background diabetic retinopathy
    ¹è°æ´ç´¢(º´)¸Á¸·º´Áõ, ºñÁõ½Ä´ç´¢(º´)¸Á¸·º´Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • background retinopathy ´ç´¢
    ¹è°æ¼º(´ç´¢º´)¸Á¸·º´Áõ.
  • diabetic retinopathy
    ´ç´¢º´(¼º) ¸Á¸·º´Áõ.
  • diabetic retinopathy
    ´ç´¢(º´)¸Á¸·º´Áõ.
  • nonproliferative diabetic retinopathy
    ºñÁõ½Ä¼º ´ç´¢¼º ¸Á¸·º´Áõ(ÞªñòãÖàõ ÓØèñàõØÑدܻñø).
  • nonproliferative diabetic retinopathy
    ºñÁõ½Ä´ç´¢¸Á¸·º´Áõ(ÞªñòãÖÓØèñØÑدܻñø).
  • preproliferative diabetic retinopathy
    Áõ½ÄÀü´ç´¢¸Á¸·º´Áõ
  • proliferative diabetic retinopathy
    Áõ½Ä´ç´¢¸Á¸·º´Áõ(ñòãÖÓØèñØÑدܻñø).
  • proliferative diabetic retinopathy
    Áõ½Ä¼º ´ç´¢¼º ¸Á¸·º´Áõ(ñòãÖàõ ÓØèñàõ ØÑدܻñø)
  • retinopathy, diabetic
    ´ç´¢º´(¼º) ¸Á¸·Áõ(ÓØÒãÜ»(àõ) ¡­ñø)
  • simple diabetic retinopathy
    ´Ü¼ø´ç´¢¸Á¸·º´Áõ
  • background
    ¹æ»ç ¹è°æ(ÛÎÌØ), À̸é(ìÀØü), ¹èÈÄ(ÛÎý­).
  • background fluorescence
    ¹è°æÇü±¤
  • background gradient
    ¹è°æ °æ»ç
  • background inhomogeneity
    ¹è°æ ºÒ±ÕÀϼº
  • background noise
    ±âº»ÀâÀ½, ¹è°æÀâÀ½
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • background
    ¹ÙÅÁ
  • background constitutive synthesis
    ±âº» ±¸¼ºÇÕ¼º(ÐñÜâϰà÷ùêà÷)
  • low background counter
    ³·Àº¹ÙÅÁ °è¼ö±â(ͪâ¦Ðï)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diabetic
    ´ç´¢º´¼ºÀÇ, ´ç´¢º´È¯ÀÚ
  • hypertensive retinopathy
    °íÇ÷¾Ð¼º¸Á¸·º´Áõ
  • background gradient
    ¹è°æ°æ»ç
  • background inhomogeneity
    ¹è°æºÒ±ÕÀϼº
  • background noise
    ¹è°æÀâÀ½
  • background radiation
    ¹è°æ¹æ»ç¼±
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PDR pediatric radiology; peripheral diabetic retinopathy; Physicians' Desk Reference; postdelivery room;...
BDR background diabetic retinopathy
BDR Back-ground Diabetic Retinopathy
PDR Proliferative Diabetic Retinopathy; Áõ½Ä¼º ´ç´¢ ¸Á¸·Áõ
PPDR Pre-Proliferative Diabetic Retinopathy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DRS Diabetic Retinopathy Study
DR Diabetic retinopathy
ETDRS Early Treatment Diabetic Retinopathy Study
PDR Proliferative diabetic retinopathy
N-PDR non-proliferative diabetic retinopathy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • background
    ¹è°æ, À̸é, ¹èÈÄ
  • background discharge
    ¹èÈÄ ¹æÀü
  • background inhomogeneity
    ¹è°æ ºÒ±ÕÀϼº
  • background radiation
    ¹è°æ ¹æ»ç¼±
  • angiospastic retinopathy
    Ç÷°ü ¿¬Ãà ¸Á¸·º´Áõ
  • chloroquine retinopathy
    Ŭ·Î·ÎÄý ¸Á¸·º´Áõ
  • circinate retinopathy
    À±»ó ¸Á¸·º´Áõ
  • hypertensive retinopathy
    °íÇ÷¾Ð¼º ¸Á¸·º´Áõ
  • hypotensive retinopathy
    ÀúÇ÷¾Ð ¸Á¸·º´Áõ
  • Purtschers traumatic retinopathy
    Ǫ¸£Ã³ ¿Ü»ó ¸Á¸·º´Áõ
  • retinopathy :

    retoperithelium

    ¸Á»ó Á¶Á÷ ÇǸ·
  • rubellar retinopathy
    dzÁø ¸Á¸·º´Áõ
  • diabetic acidosis
    ´ç´¢¼º »êÁõ, ´ç´¢º´¼º »êÁõ
  • diabetic cataract
    ´ç´¢º´ ¹é³»Àå, ´ç´¢º´¼º ¹é³»Àå
  • diabetic coma
    ´ç´¢º´ È¥¼ö, ´ç´¢º´¼º È¥¼ö
    È¥¼ö´Â ´ç´¢º´°ú Á÷Á¢ÀûÀ¸·Î °ü·ÃÀÌ ¾ø´Â ¿©·¯ °¡Áö ¿øÀο¡ ÀÇÇÏ¿© ¹ß»ýÇÒ ¼ö ÀÖ´Ù. ´ç´¢º´°ú Á÷Á¢ °ü·ÃÀÌ ÀÖ´Â ´ÙÀ½ÀÌ ÀÖ´Â ´ÙÀ½ÀÇ ¿øÀο¡ ´ëÇÏ¿©´Â °¨º°À» ¿äÇÑ´Ù. 1
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
background retinopathy <ophthalmology, pathology> Early stage of diabetic retinopathy, it usually does not impair vision.
Origin: Gr. Pathos = disease
(09 Oct 1997)
diabetic retinopathy <ophthalmology, pathology> A major cause of blindness in diabetics. Retinal disease results from adverse effects on the blood vessels which supply the retina. Swollen retinal vessels which leak fluid into the retina are commonly seen on physical examination of the eyes. Poorly controlled insulin dependent diabetes and/or hypertension are the major risk factors.
Symptoms include decreased vision and colour perception.
Origin: Gr. Pathos = disease
(27 Sep 1997)
background level The average amount of a substance present in the environment. Originally referring to naturally occurring phenomena. Used in toxic substance monitoring.
(05 Dec 1998)
background radiation <radiobiology> Level of environmental radation due to background sources. Background sources can be natural, such as cosmic rays and natural radioactive elements (principally radon, but including other elements such as isotopes of potassium (which people get substantial amounts of in foods like bananas)).
They can also be man-made, such as from fossil-fuel combustion, everyday leakage from nuclear activities, and leftover from atmospheric nuclear weapons tests. Background radiation is usually distinguished from acute radiation, such as from medical X-rays, nuclear accidents, radioisotope therapy, or other short-term doses.
The man-made contribution to background radiation is quite small compared to the natural contribution, medical uses dominate human exposure to acute radiation.
(09 Oct 1997)
diabetic Diabetes mellitus is a disorder that is caused by the insufficient production of the pancreatic hormone insulin. Without insulin cells are unable to absorb glucose, necessary for cellular metabolism and energy production. Patients may have type I diabetes (juvenile onset) or type II diabetes (adult onset). Individuals with either condition are considered to be diabetic.
(27 Sep 1997)
diabetic acidosis Decreased pH and bicarbonate concentration in the body fluids caused by accumulation of ketone bodies in diabetes mellitus.
(05 Mar 2000)
diabetic amyotrophy A type of diabetic neuropathy that primarily affects elderly patients with diabetes mellitus; clinically characterised by unilateral or bilateral anterior thigh pain, weakness, and atrophy; of abrupt or gradual onset and, when bilateral, of simultaneous or sequential onset, and usually asymmetrical; one type of diabetic polyradiculopathy. Sometimes referred to, erroneously, as diabetic femoral neuropathy.
(05 Mar 2000)
diabetic arthropathy A neuropathic arthropathy occurring in diabetes.
(05 Mar 2000)
diabetic cataract A cataract occurring in insulin-dependent diabetes mellitus.
(27 Sep 1997)
diabetic coma A severe metabolic derangement that occurs in the absence of insulin. Insulin allows the body to absorb glucose into cells for energy production. In the absence of insulin, the body starts to break down fats for fuel. A metabolic byproduct of fat metabolism is referred to as a ketone. The presence of elevated blood ketones in this setting is known as diabetic ketoacidosis. In extreme, untreated cases, this can lead to coma and death.
(27 Sep 1997)
diabetic dermopathy Small macules and papules of the extensor surfaces of the extremities, most commonly the shins of diabetics, which become atrophic, hyperpigmented, and occasionally undergo ulceration with scarring; may be a manifestation of microangiopathy.
(05 Mar 2000)
diabetic diet A diet prescribed in the treatment of diabetes mellitus, usually limited in the amount of sugar or readily available carbohydrate.
(12 Dec 1998)
diabetic fetopathy Fetopathy resulting from maternal diabetes, which may cause macrosomia and foetal death.
(05 Mar 2000)
diabetic foot Ulcers of the foot as a complication of diabetes. Diabetic foot, often with infection, is a common serious complication of diabetes and may require hospitalization and disfiguring surgery. The foot ulcers are probably secondary to neuropathies and vascular problems.
(12 Dec 1998)
diabetic gangrene Gangrene resulting from arteriosclerosis associated with diabetes.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • background
    ¿ø°æ
  • background
    ¹è°æ;¹ÙÅÁ»ö;¼Ò¾ç;À½¾ÇÈ¿°ú
  • diabetic
    ´ç·áº´ ȯÀÚ
  • diabetic
    ´ç´¢º´ÀÇ;´ç´¢º´ ȯÀÚ
  • maturityonset diabetic
    Áß;³ë³â¼º ´ç´¢º´ÀÇ(ȯÀÚ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á